| ||
| VEGF-C and VEGF-D Identified as Biomarkers for Avastin Resistance in ... Sacramento Bee Avastin® is approved by the US FDA in the following indications: metastatic colorectal cancer, nonsquamous-cell lung cancer, metastatic breast cancer, glioblastoma, metastatic renal cell carcinoma. The VEGF-C inhibitor, VGX-100, a key therapeutic in ... See all stories on this topic » |
| ||
| CureToday.com: News Archives - Roche's Tarceva helps lung cancer ... ZURICH (Reuters) - Roche Holding AG's cancer drug Tarceva nearly doubles the time patients with a distinct type of lung cancer live without their disease ... www.curetoday.com/index.cfm/fuseaction/news.../id/.../3178 | ||
| Roche Holding AG's Tarceva Stalls Lung Cancer With Gene Mutation ... The genetically distinct type of lung cancer studied in EURTAC (epidermal growth factor receptor, or EGFR, activating mutation-positive NSCLC) occurs in ... www.biospace.com/news_story.aspx?NewsEntityId=222815 |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment